Dr. Sarah Meira Benchaya, MD

Dr. Meira Benchaya practices at Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare.

Dr. Meira Benchaya's NPI, 1831503101, was assigned on June 16, 2014. Dr. Meira Benchaya holds Connecticut license 61794.

Dr. Meira Benchaya's primary practice is Hartford Hospital, at 80 Seymour Street, Hartford, CT 06102 in Hartford County. The practice phone is (860) 545-5000.

Dr. Meira Benchaya's primary practice is Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare. Dr. Meira Benchaya is also affiliated with The Hospital of Central Connecticut. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Meira Benchaya to 4 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meira Benchaya practices, 6 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Meira Benchaya's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Meira Benchaya is licensed in Connecticut.

CMS data shows 252 Medicare services from Dr. Meira Benchaya across 8 procedure codes in 2024, for 218 Medicare patients. Medicare paid $18,121 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 218 Medicare patients who saw Dr. Meira Benchaya in 2024. The largest group is under 65, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meira Benchaya's median patient age at 57, with 51% women.

In 2024, Dr. Meira Benchaya wrote 946 Medicare Part D claims for 170 patients. 86% of them were for generic drugs. CMS names the drug for 888 of them, across 23 drugs with 11 or more claims each, at $342,788 in total drug cost. In 2023, CMS named 574 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Meira Benchaya for performance year 2024, reported as part of a group. Dr. Meira Benchaya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meira Benchaya as offering telehealth.

CMS Open Payments shows 6 general payments to Dr. Meira Benchaya from 2 drug and device companies in 2019. Travel and lodging make up the largest share, 73% of the total. Neuropace, Inc. paid the most, $1,584.